
1
Retatrutide
Retatrutide is designed to activate three receptors: GLP-1R, GIPR, and the glucagon receptor. In research and clinical settings, this combination is associated with reduced appetite and slower gastric emptying signals (GLP-1R), enhanced incretin driven insulin secretion (GIPR and GLP-1R), and energy expenditure and lipid metabolism readouts linked to glucagon receptor agonism.
2
BPC-157
BPC-157 is studied as a repair signaling peptide that can shift how cells attach, move, and rebuild damaged tissue. In tendon explant and fibroblast systems, it is linked to focal adhesion signaling and cell migration behavior. In vascular endothelial systems, it is associated with VEGFR2-driven angiogenic signaling and nitric oxide related pathways that influence perfusion during healing.
3
CJC-1295 no DAC
Area & performance
Description
Appetite & Satiety Signalling
9/10
How appetite is regulated through GLP-1 and GIP receptor agonism — a central focus of Retatrutide clinical and preclinical research.
Body Weight Regulation
9/10
Human trials have examined body weight endpoints as a primary outcome measure in Retatrutide research.
Metabolic Signalling
9/10
How incretin pathways link with glucagon biology to influence metabolic signalling — a defining feature of the triple agonist mechanism.
Glucagon Receptor Biology
8/10
How triple receptor agonism adds a glucagon-mediated metabolic dimension distinct from dual incretin compounds.
Incretin Pathway Research
8/10
How GIP and GLP-1 receptor co-activation is studied in the context of metabolic and endocrine signalling models.
Gastrointestinal Tolerability
7/10
How gastrointestinal response profiles are documented in clinical trial participants — a standard area of study for incretin-based compounds.
-6.png)

-3.png)
Dr. Ania M. Jastreboff
PhD, MD
"Treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures."
.png)

01
Safety seal
We make sure you are the first person to open the compound after its production. The seal means the compound is genuine, tested, and sterile.
02
Rigid packaging
Compounds of other peptide companies are delivered without boxes. Best case: a bubble wrap. We developed a box that keeps the vial protected at all times.
03
Batch number
The batch number is always accessible on the packaging and the vial. You can always cross-reference it with the data base of COAs on our website for the assurance.

01
Safety seal
We make sure you are the first person to open the compound after its production. The seal means the compound is genuine, tested, and sterile.
02
Rigid packaging
Compounds of other peptide companies are delivered without boxes. Best case: a bubble wrap. We developed a box that keeps the vial protected at all times.
03
Batch number
The batch number is always accessible on the packaging and the vial. You can always cross-reference it with the data base of COAs on our website for the assurance.
2-day EU delivery
ISO standard compliance
Verified >99% purity for every peptide
Proper -50°C warehouse & courier storage
Sterile production and packaging
Protective packaging
EU stores
Overseas suppliers